
Nigel H. Plumb
Examiner (ID: 13796, Phone: (571)272-8886 , Office: P/2855 )
| Most Active Art Unit | 2855 |
| Art Unit(s) | 2855 |
| Total Applications | 921 |
| Issued Applications | 794 |
| Pending Applications | 74 |
| Abandoned Applications | 69 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 19096415
[patent_doc_number] => 20240115642
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => Composition for preventing hair loss or promoting hair growth comprising milk thistle flower extract as an active ingredient
[patent_app_type] => utility
[patent_app_number] => 18/013343
[patent_app_country] => US
[patent_app_date] => 2022-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8078
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18013343
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/013343 | Composition for treating hair loss or promoting hair growth comprising milk thistle flower extract as an active ingredient | Aug 17, 2022 | Issued |
Array
(
[id] => 19510421
[patent_doc_number] => 20240342107
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => CANCER THERAPEUTIC AGENT
[patent_app_type] => utility
[patent_app_number] => 18/683397
[patent_app_country] => US
[patent_app_date] => 2022-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7398
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18683397
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/683397 | CANCER THERAPEUTIC AGENT | Aug 15, 2022 | Pending |
Array
(
[id] => 19510418
[patent_doc_number] => 20240342104
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => DOSAGE FORM FOR IMPROVING PALATABILITY OF DRUG SUBSTANCE
[patent_app_type] => utility
[patent_app_number] => 18/682481
[patent_app_country] => US
[patent_app_date] => 2022-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3200
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18682481
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/682481 | DOSAGE FORM FOR IMPROVING PALATABILITY OF DRUG SUBSTANCE | Aug 10, 2022 | Pending |
Array
(
[id] => 20218487
[patent_doc_number] => 20250281418
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-11
[patent_title] => LIPID NANOPARTICLE FORMULATIONS AND METHODS OF SYNTHESIS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/682685
[patent_app_country] => US
[patent_app_date] => 2022-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31475
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18682685
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/682685 | LIPID NANOPARTICLE FORMULATIONS AND METHODS OF SYNTHESIS THEREOF | Aug 9, 2022 | Pending |
Array
(
[id] => 18034590
[patent_doc_number] => 20220378805
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => CONCENTRATED LIQUID PHARMACEUTICAL FORMULATIONS OF FUROSEMIDE
[patent_app_type] => utility
[patent_app_number] => 17/817731
[patent_app_country] => US
[patent_app_date] => 2022-08-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25255
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17817731
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/817731 | Concentrated liquid pharmaceutical formulations of furosemide | Aug 4, 2022 | Issued |
Array
(
[id] => 18034591
[patent_doc_number] => 20220378806
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => CONCENTRATED LIQUID PHARMACEUTICAL FORMULATIONS OF FUROSEMIDE
[patent_app_type] => utility
[patent_app_number] => 17/879041
[patent_app_country] => US
[patent_app_date] => 2022-08-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17879041
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/879041 | Concentrated liquid pharmaceutical formulations of furosemide | Aug 1, 2022 | Issued |
Array
(
[id] => 18182867
[patent_doc_number] => 20230043597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => CALCIUM GLUCONATE FORMULATION WITHOUT CALCIUM SACCHARATE
[patent_app_type] => utility
[patent_app_number] => 17/871058
[patent_app_country] => US
[patent_app_date] => 2022-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4643
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17871058
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/871058 | Calcium gluconate formulation without calcium saccharate | Jul 21, 2022 | Issued |
Array
(
[id] => 19477962
[patent_doc_number] => 20240326004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => POLYAMIDE-BASED MICROCAPSULES
[patent_app_type] => utility
[patent_app_number] => 18/578404
[patent_app_country] => US
[patent_app_date] => 2022-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22751
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18578404
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/578404 | POLYAMIDE-BASED MICROCAPSULES | Jul 19, 2022 | Pending |
Array
(
[id] => 18164592
[patent_doc_number] => 20230031188
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-02
[patent_title] => Methods of Treating Skin Diseases
[patent_app_type] => utility
[patent_app_number] => 17/869482
[patent_app_country] => US
[patent_app_date] => 2022-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6877
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17869482
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/869482 | Methods of Treating Skin Diseases | Jul 19, 2022 | Abandoned |
Array
(
[id] => 18107796
[patent_doc_number] => 20230000676
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-05
[patent_title] => FLUID EXCHANGE APPARATUS FOR EXPANDABLE PORT DELIVERY SYSTEM AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/864120
[patent_app_country] => US
[patent_app_date] => 2022-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27114
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -36
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17864120
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/864120 | FLUID EXCHANGE APPARATUS FOR EXPANDABLE PORT DELIVERY SYSTEM AND METHODS OF USE | Jul 12, 2022 | Pending |
Array
(
[id] => 19372922
[patent_doc_number] => 12064461
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-20
[patent_title] => Deep penetrating topical cannabinoid compositions and methods for treating musculoskeletal inflammation and pain
[patent_app_type] => utility
[patent_app_number] => 17/811972
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 11188
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17811972
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/811972 | Deep penetrating topical cannabinoid compositions and methods for treating musculoskeletal inflammation and pain | Jul 11, 2022 | Issued |
Array
(
[id] => 18418404
[patent_doc_number] => 20230172862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS OF LEVETIRACETAM
[patent_app_type] => utility
[patent_app_number] => 17/858405
[patent_app_country] => US
[patent_app_date] => 2022-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21007
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17858405
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/858405 | EXTENDED RELEASE PHARMACEUTICAL COMPOSITIONS OF LEVETIRACETAM | Jul 5, 2022 | Abandoned |
Array
(
[id] => 17944222
[patent_doc_number] => 20220331239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => N-ACETYLCYSTEINE COMPOSITIONS AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/857587
[patent_app_country] => US
[patent_app_date] => 2022-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10234
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17857587
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/857587 | N-acetylcysteine compositions and methods | Jul 4, 2022 | Issued |
Array
(
[id] => 19401984
[patent_doc_number] => 20240285495
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => COMPOSITION COMPRISING N,N-DICARBOXYMETHYLGLUTAMIC ACID, 1,3-PROPANEDIOL, AT LEAST ONE NONIONIC SURFACTANT, AT LEAST ONE ALKALINE AGENT AND/OR AT LEAST ONE DYE
[patent_app_type] => utility
[patent_app_number] => 18/573917
[patent_app_country] => US
[patent_app_date] => 2022-06-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14155
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18573917
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/573917 | COMPOSITION COMPRISING N,N-DICARBOXYMETHYLGLUTAMIC ACID, 1,3-PROPANEDIOL, AT LEAST ONE NONIONIC SURFACTANT, AT LEAST ONE ALKALINE AGENT AND/OR AT LEAST ONE DYE | Jun 28, 2022 | Pending |
Array
(
[id] => 18860260
[patent_doc_number] => 20230414694
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-28
[patent_title] => SALINE-BASED COMPOSITION FOR PIERCING AFTERCARE
[patent_app_type] => utility
[patent_app_number] => 17/848290
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4000
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17848290
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/848290 | SALINE-BASED COMPOSITION FOR PIERCING AFTERCARE | Jun 22, 2022 | Abandoned |
Array
(
[id] => 18716433
[patent_doc_number] => 11793754
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2023-10-24
[patent_title] => Sodium hypochlorite and chlorhexidine based nanoemulsions and a method of preparation thereof
[patent_app_type] => utility
[patent_app_number] => 17/842339
[patent_app_country] => US
[patent_app_date] => 2022-06-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 5201
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 106
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17842339
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/842339 | Sodium hypochlorite and chlorhexidine based nanoemulsions and a method of preparation thereof | Jun 15, 2022 | Issued |
Array
(
[id] => 17911210
[patent_doc_number] => 20220313605
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => PHARMACEUTICAL SOLUTION OF AMLODIPINE
[patent_app_type] => utility
[patent_app_number] => 17/840829
[patent_app_country] => US
[patent_app_date] => 2022-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13881
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17840829
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/840829 | Pharmaceutical solution of amlodipine | Jun 14, 2022 | Issued |
Array
(
[id] => 19401989
[patent_doc_number] => 20240285500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => HAIR GROWTH AGENT
[patent_app_type] => utility
[patent_app_number] => 18/571529
[patent_app_country] => US
[patent_app_date] => 2022-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5132
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18571529
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/571529 | HAIR GROWTH AGENT | Jun 14, 2022 | Pending |
Array
(
[id] => 20491454
[patent_doc_number] => 12533309
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2026-01-27
[patent_title] => Minoxidil adjuvant therapies
[patent_app_type] => utility
[patent_app_number] => 17/806363
[patent_app_country] => US
[patent_app_date] => 2022-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 17496
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 130
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17806363
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/806363 | Minoxidil adjuvant therapies | Jun 9, 2022 | Issued |
Array
(
[id] => 19387997
[patent_doc_number] => 20240277867
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-22
[patent_title] => A PHOTORESPONSIVE DELIVERY SYSTEM BASED ON A MODIFIED PAMAM AND METHODS THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/566778
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22919
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18566778
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/566778 | A PHOTORESPONSIVE DELIVERY SYSTEM BASED ON A MODIFIED PAMAM AND METHODS THEREOF | Jun 8, 2022 | Pending |